163 related articles for article (PubMed ID: 30246736)
21. Venetoclax for arsenic-resistant acute promyelocytic leukaemia.
Wang QQ; Wang HF; Zhao JZ; Naranmandura H; Jin J; Zhu HH
Br J Haematol; 2022 Jun; 197(5):e58-e60. PubMed ID: 35176809
[No Abstract] [Full Text] [Related]
22. Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.
Boddu P; Schlette E; Thakral B; Tang G; Pemmaraju N; Kadia T; Ferrajoli A; Ravandi F; Wierda W; Jain N
Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):161-165. PubMed ID: 28830803
[TBL] [Abstract][Full Text] [Related]
23. Arsenic and apoptosis in the treatment of acute promyelocytic leukemia.
Look AT
J Natl Cancer Inst; 1998 Jan; 90(2):86-8. PubMed ID: 9450562
[No Abstract] [Full Text] [Related]
24. A call to action for the treatment of acute promyelocytic leukemia in the modern era: It is no longer just about the ATRA and arsenic.
Pemmaraju N
Cancer; 2021 Aug; 127(16):2867-2869. PubMed ID: 33891316
[No Abstract] [Full Text] [Related]
25. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
26. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
[TBL] [Abstract][Full Text] [Related]
27. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.
Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M
Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603
[TBL] [Abstract][Full Text] [Related]
28. Towards Optimizing Risk-adapted Treatment of APML in ATRA/ATO Era: How Can Prediction of Early Mortality Help?
Buhtoiarov IN
J Pediatr Hematol Oncol; 2021 May; 43(4):158. PubMed ID: 33625082
[No Abstract] [Full Text] [Related]
29. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia.
Parma M; Casaroli I; Pogliani EM
Haematologica; 1996; 81(4):379-80. PubMed ID: 8870387
[No Abstract] [Full Text] [Related]
30. Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment.
Shinjo K; Takeshita A; Sahara N; Kobayashi M; Nakamura S; Shigeno K; Naito K; Maekawa M; Ohnishi K; Ohno R
Intern Med; 2005 Aug; 44(8):818-24. PubMed ID: 16157979
[TBL] [Abstract][Full Text] [Related]
31. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.
Stentoft J; Nielsen JL; Hvidman LE
Leukemia; 1994; 8 Suppl 2():S77-80. PubMed ID: 7815844
[TBL] [Abstract][Full Text] [Related]
32. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL).
Fujita H; Ishikawa Y; Yokoyama Y
Int J Hematol; 2020 Jun; 111(6):747-760. PubMed ID: 32347422
[No Abstract] [Full Text] [Related]
33. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
Sasaki M; Sugimoto K; Isobe Y; Oshimi K
Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
[No Abstract] [Full Text] [Related]
34. Intraventricular thrombosis during all-trans retinoic acid treatment in acute promyelocytic leukemia.
Torromeo C; Latagliata R; Avvisati G; Petti MC; Mandelli F
Leukemia; 2001 Aug; 15(8):1311-3. PubMed ID: 11480580
[No Abstract] [Full Text] [Related]
35. Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia.
Kennedy GA; Marlton P; Cobcroft R; Gill D
Br J Haematol; 2000 Dec; 111(4):1103-5. PubMed ID: 11167746
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
Kayser S; Schlenk RF; Lebon D; Carre M; Götze KS; Stölzel F; Berceanu A; Schäfer-Eckart K; Peterlin P; Hicheri Y; Rahme R; Raffoux E; Chermat F; Krause SW; Aulitzky WE; Rigaudeau S; Noppeney R; Berthon C; Görner M; Jost E; Carassou P; Keller U; Orvain C; Braun T; Saillard C; Arar A; Kunzmann V; Wemeau M; De Wit M; Niemann D; Bonmati C; Schwänen C; Abraham J; Aljijakli A; Haiat S; Krämer A; Reichle A; Gnadler M; Willekens C; Spiekermann K; Hiddemann W; Müller-Tidow C; Thiede C; Röllig C; Serve H; Bornhäuser M; Baldus CD; Lengfelder E; Fenaux P; Platzbecker U; Adès L
Haematologica; 2021 Dec; 106(12):3100-3106. PubMed ID: 34047178
[TBL] [Abstract][Full Text] [Related]
37. Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
Breccia M; Latagliata R; Carmosino I; Cannella L; Diverio D; Guarini A; De Propris MS; Petti MC; Avvisati G; Cimino G; Mandelli F; Lo-Coco F
Haematologica; 2008 Dec; 93(12):1918-20. PubMed ID: 18945746
[No Abstract] [Full Text] [Related]
38. Microgranular variant of acute promyelocytic leukemia with cytoplasmic projections resembling micromegakaryocytes.
Jiang W; Lee SH
Blood; 2018 Nov; 132(21):2314. PubMed ID: 30467190
[No Abstract] [Full Text] [Related]
39. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
Degos L
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
[TBL] [Abstract][Full Text] [Related]
40. [Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report and literature review].
Song LX; Zhou LY; Li X
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):948-50. PubMed ID: 23363754
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
